Once-daily azithromycin in the treatment of adult skin and skin-structure infections.

@article{AmayaTapia1993OncedailyAI,
  title={Once-daily azithromycin in the treatment of adult skin and skin-structure infections.},
  author={Gerardo Amaya-Tapia and Guadalupe Aguirre-Avalos and J Andrade-Villanueva and G Peredo-Gonz{\'a}lez and R. Morf{\'i}n-Otero and S. Esparza-Ahumada and E. Rodr{\'i}guez-Noriega},
  journal={The Journal of antimicrobial chemotherapy},
  year={1993},
  volume={31 Suppl E},
  pages={129-35}
}
The aim of this prospective, blinded, randomized study was to demonstrate the efficacy and safety of oral azithromycin and dicloxacillin in the treatment of adults with acute skin and skin-structure infections. Sixty-two patients were included in the intent-to-treat group and 60 were evaluable for analysis. Azithromycin was given as a 500 mg once-daily dose for three days and dicloxacillin as 250 mg qid for seven days. Isolated pathogens included primarily Staphylococcus aureus, Streptococcus… CONTINUE READING